Dr Vikas Duhan

Researcher biography
Dr Vikas Duhan is an emerging leader in immunology, with a research focus on the mechanisms that regulate T cell and natural killer (NK) cell responses in cancer and chronic infections. His work aims to advance next-generation immunotherapies by investigating how immune cell function is regulated and can be therapeutically harnessed. His current research explores post-transcriptional regulation and adaptor protein signalling pathways that govern T cell and NK cell function. Building on fundamental immunology, he aims to develop improved adoptive cell therapies, including CAR-T cells, to enhance anti-tumour efficacy and patient outcomes.
Dr Duhan completed his PhD in Viral Immunology at the University of Duisburg-Essen, Germany, followed by a Deutsche Forschungsgemeinschaft (DFG) International Fellowship at QIMR Berghofer with Prof. Rajiv Khanna, where he developed expertise in human T cell engineering and translational cancer immunotherapy.
His work has been published in leading journals, including Nature Communications, Cancer Immunology Research, PNAS, Cell Death & Differentiation, and PLOS Pathogens. He has also contributed to the development of a commercially licensed anti-CEACAM1 therapeutic antibody.